Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects
Abstract Cancer poses a significant global health challenge, with predictions of increasing prevalence in the coming years due to limited prevention, late diagnosis, and inadequate success with current therapies. In addition, the high cost of new anti-cancer drugs creates barriers in meeting the med...
Main Authors: | Roohi Mohi-ud-din, Apporva Chawla, Pooja Sharma, Prince Ahad Mir, Faheem Hyder Potoo, Željko Reiner, Ivan Reiner, Dilek Arslan Ateşşahin, Javad Sharifi-Rad, Reyaz Hassan Mir, Daniela Calina |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | European Journal of Medical Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40001-023-01275-4 |
Similar Items
-
Evolution of Natural Product Scaffolds as Potential Proteasome Inhibitors in Developing Cancer Therapeutics
by: Reyaz Hassan Mir, et al.
Published: (2023-03-01) -
An overview of current strategies and future prospects in drug repurposing in tuberculosis
by: Dilpreet Singh, et al.
Published: (2023-02-01) -
Repurposing Antipsychotics for Cancer Treatment
by: Nikolaos Vlachos, et al.
Published: (2021-11-01) -
In Vitro Drug Repurposing: Focus on Vasodilators
by: Eduarda Ribeiro, et al.
Published: (2023-02-01) -
Melatonin as a Repurposed Drug for Melanoma Treatment
by: Rachana Pathipaka, et al.
Published: (2023-01-01)